4DMedical Limited (FDMDF) Research

4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging. The company's offerings further extend to a software-as-a-service (SaaS) delivery model, alongside its proprietary XV lung ventilation analysis software. Additional products include Permetium, a preclinical imaging system designed to quantify localized changes in pulmonary function, and the AccuVent 200, a ventilator specifically tailored for small animals. Established in 2012, 4DMedical Limited is headquartered in Carlton, Australia.

Market snapshot

Symbol
FDMDF
Price
$2.70
Day change
0.00%
Market cap
$2.7B
P/E ratio
-14.10x
52-week range
0.16245-5
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • Allergy Therapeutics plc (AGYTF)
  • Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF)
  • PolyNovo Limited (CALZF)
  • CellaVision AB (publ) (CLVSF)
  • Avisa Diagnostics Inc. (FOGCF)
  • GenSight Biologics S.A. (GSGTF)
  • Lattice Biologics Ltd. (LBLTF)
  • ManifestSeven Holdings Corporation (MNFSF)

Open 4DMedical Limited (FDMDF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.